SCIESCOPUSQ1
PROGRESS IN CARDIOVASCULAR DISEASES
W B SAUNDERS CO-ELSEVIER INC, United States
PROGRESS IN CARDIOVASCULAR DISEASES is an academic journal published by W B SAUNDERS CO-ELSEVIER INC (United States). Identifiers: ISSN 0033-0620, eISSN 1873-1740. Indexed in SCIE, SCOPUS. Metrics: JIF 7.6, CiteScore 10.4, SJR 1.815, SNIP 1.92. Subject areas: CARDIAC & CARDIOVASCULAR SYSTEM, CARDIAC & CARDIOVASCULAR SYSTEMS. tlooto lists 3,145 papers from this journal.
CiteScore
10.40
Scopus 引用指标
SJR
1.815
SCImago 排名
SNIP
1.92
来源标准化影响
百分位排名
-
JIF 百分位排名
期刊资料
- ISSN
- 0033-0620
- eISSN
- 1873-1740
- 缩写
- PROG CARDIOVASC DIS
- 出版商
- W B SAUNDERS CO-ELSEVIER INC
- 国家
- United States
Web of Science 类别
SCIECARDIAC & CARDIOVASCULAR SYSTEM
Scopus ASJC 类别
2705 Cardiology and Cardiovascular Medicine
关键词
Cardiac & Cardiovascular System
Papers in this journal
Recent papers
- The new life of myectomy in the era of myosin inhibitors.
2026 · 1 citations
- Beyond body weight and BMI: Shifting the focus to excessive, ectopic, and dysfunctional adiposity.
2026 · 1 citations
- Wearable-derived REM sleep as a modifiable risk factor for cardiovascular disease: A multimodal prediction model in the All of Us Research Program.
2026 · 2 citations
- Lessons from ATTR-CM clinical trials: Progress, persistent disparities, and emerging treatment dilemmas.
2026
- Improving outcomes in severe mitral regurgitation due to annular calcification.
2026 · 1 citations
Most cited papers
- Beta blockade during and after myocardial infarction: an overview of the randomized trials.
1985 · 3,299 citations
- Blood flow measurements with radionuclide-labeled particles.
1977 · 2,243 citations
- Overview of epidemiology and contribution of obesity to cardiovascular disease.
2014 · 1,126 citations
- Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.
2007 · 854 citations
- Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review.
1985 · 844 citations